BiotechTube
Home/Hsiri Therapeutics/Ivan Joseph, MBA
IJ

Ivan Joseph, MBA

Chief Financial Officer

Hsiri Therapeutics

Therapeutic Areas

Infectious DiseasesMycobacterial InfectionsAntimicrobial Resistance

Hsiri Therapeutics Pipeline

DrugIndicationPhase
Mycobacterial Diseases ProgramTuberculosis (TB) and Non-Tuberculous Mycobacterial (NTM) InfectionsPre-clinical
Drug-Resistant Bacterial Infections ProgramInfections due to usual bacterial pathogens resistant to current treatmentsResearch/Pre-clinical
Drug-Resistant Fungal Infections ProgramInfections due to drug-resistant fungal pathogensResearch/Pre-clinical

Leadership Team at Hsiri Therapeutics

WC
William Claypool, M.D.
Chairman and CEO
MM
Marvin Miller, Ph.D.
Chief Scientific Officer
CF
Carrie Frey, MSC, MBA
Chief Operating Officer
View full Hsiri Therapeutics profile